MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.
about
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherenceAllergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageinARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cyclePilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study.Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015.Response to Nonallergenic Irritants in Children With Allergic and Nonallergic Rhinitis.Use of electronic medical records and biomarkers to manage risk and resource efficienciesNasal Irrigation: An Imprecisely Defined Medical Procedure.The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey.MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children.Systematic review of pathways for the delivery of allergy services.Early childhood risk factors for rhinoconjunctivitis in adolescence: a prospective birth cohort study.Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.Latest developments in allergic rhinitis in Allergy for clinicians and researchers.Emerging drugs for the treatment of perennial allergic rhinitis.Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.Allergy and Asthma Care in the Mobile Phone Era.Work productivity in rhinitis using cell phones: The MASK pilot study.Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement.Google Trends terms reporting rhinitis and related topics differ in European countries.Comparison of outcome measures in allergic rhinitis in children, adolescents and adults.Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control.Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project).CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report.European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017).Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy.In allergic rhinitis, work, classroom and activity impairments are weakly related to other outcome measures.Respiratory muscle strength and pulmonary function in children with rhinitis and asthma after a six-minute walk test.European Symposium on Precision Medicine in Allergy and Airways Diseases: Report of the European Union Parliament Symposium (October 14, 2015).Diagnostic relevance of IgE sensitization profiles to eight recombinant Phleum pratense molecules.Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis.Difficult vs. Severe Asthma: Definition and Limits of Asthma Control in the Pediatric Population.Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management.Geolocation with respect to personal privacy for the Allergy Diary app - a MASK studyMASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidencePOLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) projectVisual analogue scale for sino-nasal symptoms severity correlates with sino-nasal outcome test 22: paving the way for a simple outcome tool of CRS burdenThe nationwide program of allergic disease prevention as an implementation of GARD guidelines in Poland
P2860
Q26740215-872ABDB1-0BA6-4C73-9942-C8730AEA86BBQ26740381-76AFEDBF-6B12-4509-AE6C-6D7E718CBB56Q28077951-8FF40F6D-16DA-4EAC-A656-BEF624CF19C9Q28355722-2220D5A7-FBE1-4C55-8567-7BFA5BDD176FQ30239093-1D7CB262-621D-4233-B428-5750D6A8FF9BQ30251797-F5882498-BF7E-4F38-BB02-8B625EF4C01EQ30380004-DB099E06-A3E2-4C89-BAB1-7B8A40B51BB5Q33602020-69ED332F-5021-4EC9-BACF-3B9331AC10DCQ33748764-BD6D0D84-78C1-4C04-BB75-9F1DA20D116BQ36294156-9772A220-C6C2-4335-9CA6-D8468D984A14Q37384909-E8185A3F-F9D9-46B1-A968-E80F874984AFQ37639956-3F708CDE-571F-40EF-B63D-3FB93BC32145Q37733898-F5A0D323-04C4-4BDF-8AA0-3FA1762B5EC0Q38401392-4C2948DE-6409-454C-9B5E-549A554AAFBCQ38600884-046EE290-EE20-4943-9997-3DFB0F95609BQ38687640-A6F7FD5C-D858-4B76-BDFC-1AB40A04E23EQ38779963-00F52782-A810-4C7A-95FC-DC46F1262959Q38840881-4C8D839B-4735-461D-9A8D-E53C7C2A2CA0Q38848045-A665C1C0-BDE9-4DBD-AD57-56E24C3971C1Q38901335-E6BBEFAB-6673-4A9F-BAC8-168FCB5DA242Q38989746-01E2A9BB-73BA-4803-A149-470C5BFE336CQ39942966-79C0F3C1-F2B8-4F63-8F2B-B496701E77C9Q40050746-B47D40EB-DFCC-43DE-AEE9-90A1D71D8E14Q40165178-7F5FA48F-8140-4018-B088-F36E14FDEF58Q42643652-20553D11-ED77-4A59-B3DE-5E1DFD9ECDE1Q47096403-C8CBD5A3-A0EB-416C-9CD7-613CEECE884FQ47570104-13826845-F780-437F-B8D8-88B46C796ECBQ47632018-74517B94-CEBB-4EC3-92ED-A701BC727EF9Q47896431-B4A94348-434E-403C-8661-8415CBD54A57Q48090375-33427DE8-557C-4FB1-9E46-1A0D2665D61FQ48152974-C08B4BE5-1CA7-4C8D-9787-916DD0715B81Q55403212-30189C04-6522-408E-968C-360D005D2D19Q55409125-C874A90B-9F24-4EDA-9590-B793E284451EQ55448056-712AC2B3-5285-4913-9FB6-0162AD008D6AQ57136980-3343426D-398C-488D-807F-1EA66D6F4657Q58554427-995ADCE8-5E6F-473D-A271-0D4D4D48FCC3Q58735169-FF41264A-5929-43B3-9244-777250CCFA01Q58769591-57D076B7-B6F9-4CC6-90E4-15158CBF6AB0Q58771016-C8AAC5DD-D46F-457D-8B99-61540D2FEC94
P2860
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MACVIA-ARIA Sentinel NetworK f ...... tion guideline implementation.
@en
type
label
MACVIA-ARIA Sentinel NetworK f ...... tion guideline implementation.
@en
prefLabel
MACVIA-ARIA Sentinel NetworK f ...... tion guideline implementation.
@en
P2093
P2860
P50
P356
P1433
P1476
MACVIA-ARIA Sentinel NetworK f ...... ation guideline implementation
@en
P2093
A Bedbrook
A Ben Kheder
A F Kalyoncu
A Fink Wagner
A G Chuchalin
A Gamkrelidze
P2860
P304
P356
10.1111/ALL.12686
P50
P577
2015-09-13T00:00:00Z